• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

What’s New in Cardiovascular Disease

News
Slideshow

As the new year begins, several developments in heart health research are making the news.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
High-Quality Carbohydrates in Midlife Linked to Healthier Aging in Women / image credit Tufts School of Medicine

High-Quality Carbohydrates in Midlife Linked to Healthier Aging in Women

Grace Halsey
May 29th 2025
Article

For every 10% increase in energy from high-quality carbohydrates, the odds of healthy aging rose by 31%, according to an analysis of data from the Nurse's Health Study.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis / image credit Jorge Plutzky, MD, Brigham and Women's Hospital

Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis

Grace Halsey
May 14th 2025
Article

Semaglutide was associated with a significant reduction in risk for major adverse cardiovascular events after just 3 months of treatment in a population with established CVD.

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Patient Care Editorial Staff
October 29th 2020
Podcast

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows / Image credit: ©interstid/AdobeStock

Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows

Sydney Jennings
May 2nd 2025
Article

A simple RNA-based blood test can identify the risk of hypertensive disorders in pregnancy months before symptoms appear, researchers reported.

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes / image credit Andrew Agbaje, MD, MPH, PhD Courtesy of University of Eastern Finland

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes, Novel Cohort Study Finds

Grace Halsey
May 2nd 2025
Article

Persistent hyperglycemia between ages 17 and 24 tripled the risk of left ventricular hypertrophy and did so 5 times faster among young women, a new study found.

© 2025 MJH Life Sciences

All rights reserved.